Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBT002 in Healthy Volunteers and Participants With CRSwNP
NCT07436949Phase 2Recruiting
- Sponsor
- Bambusa Therapeutics
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of BBT002 in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by Bambusa Therapeutics. Started Mar 2026; status: recruiting.
02
Drugs
BBT002
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on NCT07436949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07436949.